• DNA X shifted director pay to cash awards in lieu of restricted stock units under its 2019 Equity Incentive Plan.
• Move follows an exhaustion of available common shares under the plan, blocking new RSU grants.
• Each award is sized off a $60,000 RSU-equivalent value using the stock’s fair market value on Aug. 21, 2026.
• Cash payout is tied to the stock price at vesting, triggered at the 2027 annual meeting or a change in control.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-040324), on August 27, 2026, and is solely responsible for the information contained therein.